Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Funding of US Biomedical Research, 2003-2008

Funding of US Biomedical Research, 2003-2008 ORIGINAL CONTRIBUTION Funding of US Biomedical Research, 2003-2008 E. Ray Dorsey, MD, MBA Context With the exception of the American Recovery and Reinvestment Act, fund- ing support for biomedical research in the United States has slowed after a decade of Jason de Roulet, MD doubling. However, the extent and scope of slowing are largely unknown. Joel P. Thompson, MPH Objective To quantify funding of biomedical research in the United States from 2003 Jason I. Reminick, MS to 2008. Ashley Thai, BS Design Publicly available data were used to quantify funding from government (fed- Zachary White-Stellato eral, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new Christopher A. Beck, PhD drug and device approvals by the US Food and Drug Administration over the same Benjamin P. George, BS period were also evaluated. Hamilton Moses III, MD Main Outcome Measures Funding and growth rates by source; numbers of US Food and Drug Administration approvals. IOMEDICAL RESEARCH IS VAL- Results Biomedical research funding increased from $75.5 billion in 2003 to $101.1 ued highly by individuals, gov- billion in 2007. In 2008, funding from the National Institutes of Health http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Loading next page...
 
/lp/american-medical-association/funding-of-us-biomedical-research-2003-2008-C4wHcPHDrG
Publisher
American Medical Association
Copyright
Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2009.1987
pmid
20068207
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL CONTRIBUTION Funding of US Biomedical Research, 2003-2008 E. Ray Dorsey, MD, MBA Context With the exception of the American Recovery and Reinvestment Act, fund- ing support for biomedical research in the United States has slowed after a decade of Jason de Roulet, MD doubling. However, the extent and scope of slowing are largely unknown. Joel P. Thompson, MPH Objective To quantify funding of biomedical research in the United States from 2003 Jason I. Reminick, MS to 2008. Ashley Thai, BS Design Publicly available data were used to quantify funding from government (fed- Zachary White-Stellato eral, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new Christopher A. Beck, PhD drug and device approvals by the US Food and Drug Administration over the same Benjamin P. George, BS period were also evaluated. Hamilton Moses III, MD Main Outcome Measures Funding and growth rates by source; numbers of US Food and Drug Administration approvals. IOMEDICAL RESEARCH IS VAL- Results Biomedical research funding increased from $75.5 billion in 2003 to $101.1 ued highly by individuals, gov- billion in 2007. In 2008, funding from the National Institutes of Health

Journal

JAMAAmerican Medical Association

Published: Jan 13, 2010

References